TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
This Transition and Succession Agreement (this “Agreement”) is dated as of January 10, 2006, by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Harry A. Korman (“Executive”).
RECEIVABLES PURCHASE AGREEMENT Dated as of February 21, 2012 among MYLAN PHARMACEUTICALS INC., individually and as Servicer, MYLAN SECURITIZATION LLC, as Seller, THE CONDUIT PURCHASERS FROM TIME TO TIME PARTY HERETO, THE COMMITTED PURCHASERS FROM TIME...Receivables Purchase Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • New York
This RECEIVABLES PURCHASE AGREEMENT dated as of February 21, 2012 (this “Agreement”), among Mylan Pharmaceuticals Inc., a West Virginia corporation (“MPI”), individually and as initial Servicer, Mylan Securitization LLC, a Delaware limited liability company, as seller (“Seller”), Market Street Funding, LLC, a Delaware limited liability company (“Market Street”), as a conduit purchaser, Working Capital Management Co, LP, a California limited partnership (“WCMC”), as a conduit purchaser, Victory Receivables Corporation, a Delaware corporation (“Victory”), as a conduit purchaser and the other conduit purchasers from time to time party hereto (each individually, a “Conduit Purchaser” and collectively with Market Street, WCMC and Victory, “Conduit Purchasers”), PNC Bank, National Association, a national banking association (“PNC”), as a committed purchaser, Mizuho Corporate Bank, Ltd, a bank organized under the laws of Japan (“Mizuho”), as a committed purchaser, SunTrust Bank, a Georgia ban
PURCHASE AND CONTRIBUTION AGREEMENT dated as of February 21, 2012 between MYLAN PHARMACEUTICALS INC., as Originator and as Servicer and MYLAN SECURITIZATION LLC, as BuyerPurchase and Contribution Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • New York
THIS PURCHASE AND CONTRIBUTION AGREEMENT dated as of February 21, 2012 (this “Agreement”) is between MYLAN PHARMACEUTICALS INC., a West Virginia corporation (“MPI”), as originator and seller (“Originator”), and as initial servicer (in such capacity, the “Servicer”), and Mylan Securitization LLC, a Delaware limited liability company (the “Buyer”). For good and valuable consideration, the sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT TO THE TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Inc. (the “Company”) and Harry A. Korman (the “Executive”), is made as of December 15, 2008.
AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 1 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Harry A. Korman (the “Executive”) is made as of April 3, 2006.
PERFORMANCE GUARANTYPerformance Guaranty • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • New York
This PERFORMANCE GUARANTY (this “Agreement”) dated as of February 21, 2012, is between MYLAN INC., a Pennsylvania corporation (“Performance Guarantor”), and THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as agent (“Agent”) on behalf of the Purchasers and other Secured Parties, from time to time, under the Receivables Purchase Agreement (as defined below) (each, including Agent, a “Beneficiary” and, collectively, the “Beneficiaries”). Capitalized terms used and not otherwise defined in this Agreement are used as defined in, or by reference in, the Receivables Purchase Agreement dated as of the date hereof among Mylan Securitization LLC (“Seller”), Mylan Pharmaceuticals Inc. (individually, “MPI”, and as initial servicer, “Servicer”), Agent, the various Purchasers from time to time party thereto, the various Purchaser Agents from time to time party thereto and LOC Issuers from time to time party thereto (the “Receivables Purchase Agreement”). The interpretive provisions set out
AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENTTransition and Succession Agreement • April 27th, 2012 • Mylan Inc. • Pharmaceutical preparations • Pennsylvania
THIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) is made as of this 15th day of October, 2009, by and between Mylan Inc., a Pennsylvania corporation (the “Company”), and Anthony Mauro (“Executive”).
